A detailed history of Emerald Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Emerald Advisors, LLC holds 26,284 shares of PFE stock, worth $692,846. This represents 0.11% of its overall portfolio holdings.

Number of Shares
26,284
Previous 25,149 4.51%
Holding current value
$692,846
Previous $703,000 8.11%
% of portfolio
0.11%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$27.7 - $31.39 $31,439 - $35,627
1,135 Added 4.51%
26,284 $760,000
Q2 2024

Jul 15, 2024

BUY
$25.26 - $29.6 $140,041 - $164,102
5,544 Added 28.28%
25,149 $703,000
Q1 2024

Apr 25, 2024

BUY
$25.89 - $29.73 $81,242 - $93,292
3,138 Added 19.06%
19,605 $544,000
Q4 2023

Jan 23, 2024

SELL
$26.13 - $33.94 $108,178 - $140,511
-4,140 Reduced 20.09%
16,467 $474,000
Q3 2023

Oct 13, 2023

BUY
$32.09 - $37.51 $157,080 - $183,611
4,895 Added 31.15%
20,607 $683,000
Q2 2023

Aug 02, 2023

BUY
$36.12 - $41.79 $52,121 - $60,302
1,443 Added 10.11%
15,712 $576,000
Q1 2023

Apr 07, 2023

BUY
$39.39 - $51.28 $20,167 - $26,255
512 Added 3.72%
14,269 $582,000
Q4 2022

Jan 20, 2023

SELL
$41.75 - $54.5 $27,763 - $36,242
-665 Reduced 4.61%
13,757 $0
Q3 2022

Oct 12, 2022

BUY
$43.76 - $53.42 $25,162 - $30,716
575 Added 4.15%
14,422 $631,000
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $31,733 - $37,625
682 Added 5.18%
13,847 $726,000
Q1 2022

Apr 26, 2022

BUY
$45.75 - $56.69 $21,273 - $26,360
465 Added 3.66%
13,165 $682,000
Q4 2021

Jan 19, 2022

BUY
$41.32 - $61.25 $72,310 - $107,187
1,750 Added 15.98%
12,700 $750,000
Q3 2021

Nov 02, 2021

BUY
$39.25 - $50.42 $6,672 - $8,571
170 Added 1.58%
10,950 $471,000
Q2 2021

Aug 02, 2021

BUY
$35.91 - $40.68 $24,706 - $27,987
688 Added 6.82%
10,780 $422,000
Q1 2021

Apr 20, 2021

BUY
$33.49 - $37.77 $5,525 - $6,232
165 Added 1.66%
10,092 $366,000
Q4 2020

Feb 05, 2021

SELL
$33.47 - $42.56 $64,362 - $81,842
-1,923 Reduced 16.23%
9,927 $365,000
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $10,826 - $12,702
341 Added 2.96%
11,850 $435,000
Q2 2020

Aug 10, 2020

SELL
$30.12 - $36.54 $9,939 - $12,058
-330 Reduced 2.79%
11,509 $376,000
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $135,339 - $193,370
-5,007 Reduced 29.72%
11,839 $441,000
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $554,570 - $629,366
16,846 New
16,846 $677,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Emerald Advisors, LLC Portfolio

Follow Emerald Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisors, LLC with notifications on news.